In this US electoral season, I find myself musing about resilience and how central it is to biology and human health. We are on the cusp of yet another cycle of change, which can lend hope but also induce anxiety. Those of us who have undergone multiple decades of change know something about how these cycles go… never exactly as we predict, but often circling back to familiar themes.
Pharmacology research gives us additional perspectives into biological resilience. As we unraveled cellular signaling pathways, we came to understand that ligands that we thought to be disparate (neurotransmitters, cytokines, growth factors, metabolic peptides, etc.) share common mechanisms for changing cell behavior, arranged in combinations that provide nuance to their effects. We also learned that a single ligand often interacts with multiple types of receptors, which are constructed of modules of sequence that are similar to, but unique from, those in other proteins. The signaling resiliency of cancer cells is legendary, and challenges us to outsmart nature. Together, these findings have led us to appreciate how drugs exert side effects, and how cells can adapt to long-term therapy with a given drug. In other words, cells are more resilient and complex than we ever dreamed possible, and our best-laid plans for drug therapy can lead to unexpected results…both negative and positive.
Resilience is also central to mentor-trainee relationships. Our trainees experience change in ways complementary to those of their mentors. Trainees are not as restricted by previous experience, which can lead them to suggest new solutions. They can also be more sensitive to change, since they have not yet built all the strategies to deal with it. Mentors need the energy and creativity of their trainees, and trainees need the long-term vision and perspective of their mentors. Together, they support each other as they move science forward. The scientific enterprise relies on these relationships, and this is why funding agencies have historically supported training grants and fellowships. ASPET provides multiple resources for scientists at all career levels to engage with mentors who can assist them in their journey. These resources include:
- MentorMatch, a platform that facilitates one-on-one mentoring relationships,
- Mentoring Network, a year-long program providing group coaching to graduate students and postdoctoral scientists,
- The SURF program, which matches undergraduates with mentors for a summer research experience, and
- The ASPET Conference Buddy Program, a peer-mentoring opportunity for first-time attendees that takes place during the ASPET Annual Meeting.
Pharmacology serves as a great example of the resilience of the human scientific endeavor. To relieve suffering, we have boldly moved forward with treatments for disease before we understood all aspects of either the disease or the treatment. We learn from our mistakes, dive deeper into the mechanisms, and strive to come up with better treatments. A drug that is abandoned due to adverse effects in one situation can be useful in another… once we understand its limitations. Patients who enroll in clinical trials do so in the belief that scientists will develop better treatments over time. Their confidence is based on the “social contract” that we will test drugs responsibly, that we will provide opportunities for patients to be part of the conversation, and that government will oversee our efforts in a responsible manner. It is our collective responsibility as pharmacologists to be part of this contract.
As change inevitably comes our way, we can draw on our belief in the value of scientific discovery to persist in our endeavors. Working together, we can be resilient and can improve the lives of others. Please take advantage of the avenues that ASPET provides for you to take your work in new directions, mentor the next generation of pharmacologists, and identify new ways to make a difference to the world.
Sincerely,
Kay Meier, PhD
President, ASPET


